Biotechnology Innovation Organization (BIO)
1225 Eye Street, NW
3347 articles about Biotechnology Innovation Organization (BIO)
Tonix Pharmaceuticals to Participate in Event Titled, “Long COVID: What Will it Take to Accelerate Therapeutic Progress?”
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will present at a virtual event co-hosted by BIO and Solve M.E.
Tuesday, a panel of experts took on stiff questions about pain/addiction therapeutics during a panel hosted by the Biotechnology Innovation Organizaion (BIO) in NYC.
A group of 25 senators, led by Sen. Elizabeth Warren (D-MA), is requesting that HHS Sec. Xavier Becerra exercise march-in rights for Xtandi (enzalutamide), a prostate cancer therapeutic.
Biotech Sector Thrives, Generating Nearly $3 Trillion Economic Impact - New Report Shows
The Biotechnology Innovation Organization and the Council of State Bioscience Associations released new data on the bioscience industry in the United States.
Biotechs, Developing Countries Vaccine Manufacturers and Pharma Unite Behind a Proposal to G20 and G7 Offering a Practical Solution for Better Access to Vaccines for Future Pandemics
The Biotechnology Innovation Organization, Developing Countries Vaccine Manufacturers’ Network and the International Federation of Pharmaceutical Manufacturers and Associations have been key players in the historic effort to scale up the manufacturing of COVID-19 vaccines.
The Biotechnology Innovation Organization, Passage Bio and Palisade Bio saw leadership shakeups at the top, while Maze Therapeutics, Cerecin and more appointed new chief medical officers.
BIO Announces Appointment of Interim CEO
The Biotechnology Innovation Organization – the world’s largest science and public advocacy organization, representing 1,000 members — announced that Rachel King, co-founder and former CEO of GlycoMimetics, Inc., has agreed to serve as interim President and CEO.
Biotechnology Innovation Organization, the world's largest science and public advocacy organization, announced Monday it has tapped Rachel King to serve as interim President and CEO.
This week's Movers & Shakers includes a number of chief business officers and business development leaders alongside those tapped for scientific roles.
Representation of women in biotech is nearing parity, but this is not reaching the executive level, where there is still stark disparity.
The annual BIO convention has returned, bringing thousands of life sciences companies worldwide to the annual networking event that could spark collaborations and deals.
The Biotechnology Innovation Organization provides a glimpse of economic development in the biosciences ecosystem at the state and regional levels.
Growing Pains at BIO as Price Control Debate Heats Up in Washington and Within the Industry
9/1/2021Multiple reports suggest an exodus of BIO team members over price control issues. BIO reorganized its leadership structure to provide what was expected to be “long-term stability for the organization.”
The panels discussed key issues such as expanded access programs (EAPs), clinical trial diversity, conditional approval pathways, and patient experience data.
BioKansas Partners With BIO to Provide Equity, Inclusion, and Career Programming
BioKansas, a non-profit organization supporting the bioscience industry has extended their partnership with the Biotechnology Innovation Organization for a second year.
BIO Chair Responds to Biden Decision on Vaccines
In response to the Biden Administration's decision to waive patent protections for COVID vaccines and raise global production, Dr. Jeremy Levin, chairman of the global Biotechnology Innovation Organization, issued the following statement
The COVID-19 pandemic is not only an international health crisis, but a burgeoning geopolitical exercise for Russia to win the hearts and minds of a large portion of the world while undermining the West.
Less than a year after taking over the reins, Biotechnology Innovation Organization Chief Executive Officer Michelle McMurry-Heath is reorganizing the organization's leadership structure.
Biocom California Joins Legal Challenge to Department of Health and Human Services’ Most Favored Nation Interim Final Rule for Drug Pricing
Biocom California, the association representing the California life science industry, joined the Biotechnology Innovation Organization and the California Life Sciences Association in filing a challenge against the Department of Health and Human Services’ recent Most-Favored Nation Interim Final Rule.
New Strategic Vision for Biotechnology Innovation Organization - Oct 27, 2020
The Biotechnology Innovation Organization announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds.